Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Apocrine and eccrine gland disorders
ADR ID BADD_A00301
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.02      Skin appendage conditions
23.02.03      Apocrine and eccrine gland disorders
Description Not Available
MedDRA Code 10002982
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01283Levorphanol tartrate--
BADD_D01285Levothyroxine0.000441%
BADD_D01286Levothyroxine sodium--
BADD_D01287Lidocaine--
BADD_D01295Linezolid0.003622%
BADD_D01299Lisdexamfetamine dimesylate--
BADD_D01300Lisinopril--
BADD_D01301Lisuride--
BADD_D01303Lithium carbonate--
BADD_D01309Lomefloxacin--
BADD_D01310Lomefloxacin hydrochloride--
BADD_D01311Lomitapide--
BADD_D01317Loratadine0.000254%
BADD_D01318Lorazepam0.000542%
BADD_D01319Lorcaserin hydrochloride--
BADD_D01320Lorcaserin hydrochloride hemihydrate--
BADD_D01321Lormetazepam--
BADD_D01322Losartan0.000034%
BADD_D01323Losartan potassium--
BADD_D01325Lovastatin--
BADD_D01328Lubiprostone--
BADD_D01330Lurasidone0.003050%
BADD_D01339Magnesium cation--
BADD_D01340Magnesium chloride--
BADD_D01343Magnesium sulfate--
BADD_D01344Magnesium sulfate heptahydrate--
BADD_D01345Magnevist--
BADD_D01349Mannitol0.000198%
BADD_D01350Maprotiline--
BADD_D01351Maprotiline hydrochloride--
The 20th Page    First    Pre   20 21 22 23 24    Next   Last    Total 38 Pages
ADReCS-Target
ADR Term Drug Name Target